Trehalose improved cell glucose consumption and decreased MDA content of cryopreserved valve cells.

Abstract

<p>Valve cells were treated with DMSO or trehalose (0–0.20 mol/L). (A) Glucose consumption, valves were cryopreserved for 4 weeks. (B) MDA, valves were cryopreserved for 4 weeks. (C) Glucose consumption, valves were cryopreserved for 16 weeks. (D) MDA, valves were cryopreserved for 16 weeks. Data are expressed as the mean ± SD (<i>n</i> = 4 per group). *<i>P</i> < 0.05, **<i>P</i> < 0.01 versus the DMSO group.</p